Caricamento...
Estimating the clinical cost of drug development for orphan versus non-orphan drugs
BACKGROUND: High orphan drug prices have gained the attention of payers and policy makers. These prices may reflect the need to recoup the cost of drug development from a small patient pool. However, estimates of the cost of orphan drug development are sparse. METHODS: Using publicly available data,...
Salvato in:
| Pubblicato in: | Orphanet J Rare Dis |
|---|---|
| Autori principali: | , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
BioMed Central
2019
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6327525/ https://ncbi.nlm.nih.gov/pubmed/30630499 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13023-018-0990-4 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|